Skip to main content

Martinez Ramirez, Maria

I graduated in medicine from the Autonomous University of Barcelona in 2016, studied the MIR and later specialized in psychiatry at the Consorci Sanitari del Maresme - Mataró Hospital in 2021. Once I finished the residency I spent some time working in community child psychiatry (CSMIJ Ocata) and in the Adult Day Hospital of the Mataró Hospital. Since December 2022, I have been developing my professional activity in the Comprehensive Care for Autism Spectrum Disorder (PAITEA) program of the Mental Health Service of the Vall d'Hebron University Hospital.

Institutions of which they are part

Predoctoral researcher
Psychiatry, Mental Health and Addictions
Vall Hebron Institut de Recerca
Psychiatrics
General Hospital

Martinez Ramirez, Maria

Institutions of which they are part

Predoctoral researcher
Psychiatry, Mental Health and Addictions
Vall Hebron Institut de Recerca
Psychiatrics
General Hospital

I graduated in medicine from the Autonomous University of Barcelona in 2016, studied the MIR and later specialized in psychiatry at the Consorci Sanitari del Maresme - Mataró Hospital in 2021. Once I finished the residency I spent some time working in community child psychiatry (CSMIJ Ocata) and in the Adult Day Hospital of the Mataró Hospital. Since December 2022, I have been developing my professional activity in the Comprehensive Care for Autism Spectrum Disorder (PAITEA) program of the Mental Health Service of the Vall d'Hebron University Hospital.

After passing the extraordinary entrance test for the specialist title in Child and Adolescent Psychiatry in 2023, I have a double specialization (both in adult psychiatry and in child and adolescent psychiatry).

I have collaborated in the publication of several articles on multiple topics (cycloid psychosis and anti-NMDA encephalitis, psychedelics and autism). Since 2017 I have been a member of the Spanish Society of Psychiatry and Mental Health and the Catalan Society of Psychiatry and Mental Health.

Related news

Irritability in ADHD and BDP is an understudied symptom that has a major impact on patients' quality of life and may even increase the risk of suicide.

These results reinforce the need for more individualized attention to address educational needs from an early stage.

On World Clinical Trials Day, we highlight some of the studies we have participated in that confirm the efficacy of new drugs, allowing their approval by regulatory agencies.

Related professionals

Maria Antonia Ramon Belmonte

Maria Antonia Ramon Belmonte

Senior researcher
Pneumology
Read more
Andres Francisco Pacheco Reyes

Andres Francisco Pacheco Reyes

Shock, Organ Dysfunction and Resuscitation
Read more
Ana  Román Mora

Ana Román Mora

Secretary
Communication Unit
Communication Directorate
Read more
Rafael Castilla Gomez

Rafael Castilla Gomez

Zelador/a
General Services and Infrastructures Unit
Manager
Read more

Subscribe to our newsletters and be part of the Campus life

We are a world-leading healthcare complex where healthcare, research, teaching and innovation go hand in hand.

This question is for testing whether or not you are a human visitor and to prevent automated spam submissions.